Form D · Biotechnology
ILIAD BIOTECHNOLOGIES, INC.
Weston, FL · CIK 0002112659
Offering snapshot reported Feb 20, 2026 · SEC filing
- Reported sold
- $116M Offering amount: $116M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2026 | Initial | $115,540,057 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.15M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-574168
The above amount excludes the conversion at the closing of $2,639,385.75 of outstanding indebtedness.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Walter C. Greenblatt | 4723413 | Walter C. Greenblatt & Associates · CRD 129291 |
Source: Form D, filed Feb 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mario Barro | Director |
| Eric Edidin | Director |
| Avi Naider | Director |
| Keith Rubin | Director, Executive |
| William Steinkrauss | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4581 Weston Road Suite 260
Weston, FL, 33331
Weston, FL, 33331